GENX Generix Group SA

Generix Group - Third Quarter Revenue 2021 / 2022: €20.5 M, in line with latest forecasts

Generix Group - Third Quarter Revenue 2021 / 2022: €20.5 M, in line with latest forecasts

PRESS RELEASE

Paris, January 27, 2022

Q3 2021/2022 revenues: 20.5 M, in line with latest forecasts

New SaaS contracts Q3 2021/2022: 1.4 M

Confirmation of financial objectives for the year

Generix Group, Industrial, Logistics and Retail Ecosystems provider with leading Collaborative SaaS Solutions, publishes today its revenues for the third quarter of the 2021/2022 fiscal year.

Q3 revenues: €20.5 million (-0.9%)



 

 Trimestre clos

le 31 décembre
Variation 9 mois clos

le 31 décembre
Variation
Non audité (K€)2021202020212020
SaaS                         8 531                            8 3752%                           25 193                           24 0715%
Maintenance                         4 771                            4 5126%                           13 994                           13 4894%
Licences                            711                               974-27%                             3 253                             2 83415%
Activités d'Edition                       14 013                          13 8611,1%                           42 440                           40 3945,1%
Conseil & Services                         6 531                            6 875-5%                           19 580                           18 4426%
Chiffre d'Affaires                       20 544                          20 736-0,9%                           62 020                           58 8365,4%



 

 

Revenues for the past quarter amounted to €20.5 million, down 0.9% compared to Q3 of the previous year. As a result, revenue growth was +5.4% for the first nine months of the year. 

 

As announced at the time of the presentation of the half-year results, the Group is experiencing a temporary slowdown in its sales of Licenses, Consulting & Services in North America. This trend, which began at the end of the second quarter, has led the Group to replace the Managing Director of this Business Unit, which has enabled the commercial indicators to be revived. The return to a normal level of activity should be achieved during the first half of the next fiscal year.

New SaaS contracts Q3: 1.4 M (+2.3%)

 Quarter ended December 31Change9 months ended December 31Change
Unaudited (K€)2021202020212020
New SaaS contract signing (ACV*)1 3801 3492,3%3 7172 53046,9%

 * New signatures expressed in ACV (Annual Contract Value) highlighting the average annual additional revenue that will be generated after deployment of the contracts concerned.

As a reminder, in the previous year, the health crisis led to a slowdown in new SaaS contract signatures over the first six months, followed by an acceleration in the second half of the year.

With an additional growth of 2.3% compared to Q3 of the previous fiscal year, the growth of signatures during the first 9 months of the fiscal year amounts to +46.9%.

The last 12 consecutive months are among the Group's highest levels of signatures ever, amounting to €5.9 million.

Among these new signatures, it is worth noting:

  • the signature in North America of a major player in the distribution of spare parts for automobiles, which has chosen Generix Group's Solochain WMS solution to manage its warehouse, which benefits in particular from a new ASRS (Automated Storage and Retrieval System) with which the Generix solution will be interfaced. The ability of Generix's solution to connect to these new warehouse technologies has been a real asset.



  • a new Italian customer, an international packaging supplier who has chosen the Generix Group Warehouse Management System (WMS), Transport Management System (TMS) and Supply Chain Visibility solutions for 19 warehouses in 2 countries in its EMEA zone.



These contracts confirm Generix Group's ability to win the trust of major players throughout the supply chain.

Confirmation of financial objectives for the year



Generix Group confirms the outlook announced at the time of the presentation of its half-yearly financial statements: growth that is a few points lower than the double-digit growth previously expected and comparable to that recorded over the first nine months of the year.

The signing dynamic remains at high levels and should continue over the at the end of the year.

The Group maintains its forecast of a stable EBITDA margin compared to the previous fiscal year, with a sustained policy of investment in R&D, and in Sales and Marketing to capture market growth.

Supplemental and non-IFRS Financial Information

Supplemental non-IFRS information (above-mentioned as EBITDA) presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Company’s supplemental non-IFRS financial information may not be comparable to similarly titled non-IFRS measures used by other companies.

Next financial press release: April 26th, 2022, after market closes

Publication of the yearly revenue

About Generix Group



Generix Group is a Collaborative Supply Chain expert present in 60 countries, thanks to its subsidiaries and network of partners. More than 6,000 companies around the world use its SaaS solutions. The group’s 800 employees provide daily support for such customers as Carrefour, Danone, FM Logistic, Fnac-Darty, Essilor, Ferrero and Geodis in the digital transformation of their Supply Chain.

Its collaborative platform, Generix Supply Chain Hub, helps companies to keep the promises they make to their customers. It combines the capabilities to execute physical flows, digitalize information flows, manage collaborative processes and connect companies to all their partners, in real time.

Generix Supply Chain Hub is aimed at all players in the Supply Chain: manufacturers, third- and fourth-party logistics providers (3PL/4PL) and retailers.

Founded in France in 1990, the company is listed on the Eurolist market of Euronext Paris, compartment C (ISIN: FR0010501692). To learn more:

 

Attachment



EN
27/01/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Generix Group SA

 PRESS RELEASE

Generix Group : Aïda Collette-Sène nommée Présidente du directoire de ...

Generix Group : Aïda Collette-Sène nommée Présidente du directoire de Generix Group                Communiqué de presse      Le 15 septembre 2022 Aïda Collette-Sène nommée Présidente du directoire de Generix Group Generix Group annonce que le Conseil de Surveillance a nommé Madame Aïda Collette-Sène aux fonctions de Présidente du Directoire, à compter du 1er septembre 2022. Directrice Générale de Generix Group depuis avril 2018, après un parcours de près de 20 ans au sein du groupe CGI, elle prend la succession de Monsieur Jean-Charles Deconninck qui dirigeait la société depui...

 PRESS RELEASE

Generix Group - Information relative au nombre total de droits de vote...

Generix Group - Information relative au nombre total de droits de vote et d’actions au 31 août 2022 COMMUNIQUE FINANCIER Lesquin, le 9 Septembre 2022 Generix Group - Information relative au nombre total de droits de vote et d’actions Prévue par l’article L. 233-8 II du Code de Commerce et l’article 223-16 du règlement général de l’Autorité des Marchés Financiers DateNombre d’actionsNombre de droits de vote théoriques des actions31/08/202222 703 86323 198 086 FR À propos de Generix Group  Generix Group est un expert de la Supply Chain Collaborative présent dans plus de 60 pays, grâce à...

 PRESS RELEASE

Résultat de l’Offre Publique d’Achat Simplifiée

Résultat de l’Offre Publique d’Achat Simplifiée Generix Group          Communiqué de presse          Le 25 août 2022 Résultat de l’Offre Publique d’Achat Simplifiée Generix Group et New Gen Holding annoncent que le 24 août 2022, l’Autorité des marchés financiers a publié les résultats de l’offre publique d’achat simplifiée clôturée le 19 août 2022 et visant la totalité des actions Generix Group non détenues par New Gen Holding. A l’issue de l’offre publique d’achat simplifiée, l’Initiateur New Gen Holding a acquis 6 589 041 actions dans le cadre de la procédure de semi-centralisation. ...

 PRESS RELEASE

Generix Group - Information relative au nombre total de droits de vote...

Generix Group - Information relative au nombre total de droits de vote et d’actions au 31 juillet 2022 COMMUNIQUE FINANCIER Lesquin, le 8 Août 2022 Generix Group - Information relative au nombre total de droits de vote et d’actions Prévue par l’article L. 233-8 II du Code de Commerce et l’article 223-16 du règlement général de l’Autorité des Marchés Financiers DateNombre d’actionsNombre de droits de vote théoriques des actions31/07/202222 703 86323 756 862 FR À propos de Generix Group  Generix Group est un expert de la Supply Chain Collaborative présent dans plus de 60 pays, grâce à s...

 PRESS RELEASE

Generix Group - Bilan semestriel du contrat de liquidité GENERIX contr...

Generix Group - Bilan semestriel du contrat de liquidité GENERIX contracté avec NATIXIS ODDO BHF COMMUNIQUE FINANCIER Lesquin, le 3 Aout 2022 Generix Group - Bilan semestriel du contrat de liquidité GENERIX contracté avec NATIXIS ODDO BHF Au titre du contrat de liquidité confié à NATIXIS ODDO BHF portant sur les actions de la société GENERIX, à la date du 30 Juin 2022, les moyens suivants figuraient au compte de liquidité : 27 099 titres GENERIX50 430.95€         Lors du dernier bilan semestriel, à la date du 31 Décembre 2021, les moyens suivants figuraient au compte de liquidité :   ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch